Literature DB >> 10419786

Prostaglandins and bone: physiology and pathophysiology.

L G Raisz1.   

Abstract

Prostaglandins (PGs) are potent stimulators of bone formation and resorption and are produced by bone cells. PGs also have inhibitory effects on fully differentiated osteoblasts and osteoclasts. This complex, multifunctional regulation is probably mediated by different PG receptors. Endogenous PGs in bone are produced largely by induction of COX-2, which is highly regulated by hormones and local factors. The development of specific agonists and antagonists for PG receptors and for COX-2 should allow us to define the physiologic and pathophysiologic roles of PGs more precisely and develop new therapeutic approaches to metabolic and inflammatory disorders of the skeleton. Copyright 1999 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419786     DOI: 10.1053/joca.1998.0230

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  42 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Alteration of femoral bone morphology and density in COX-2-/- mice.

Authors:  Galen Robertson; Chao Xie; Di Chen; Hani Awad; Edward M Schwarz; Regis J O'Keefe; Robert E Guldberg; Xinping Zhang
Journal:  Bone       Date:  2006-05-30       Impact factor: 4.398

3.  The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study.

Authors:  J B Richards; L Joseph; K Schwartzman; N Kreiger; A Tenenhouse; D Goltzman
Journal:  Osteoporos Int       Date:  2006-06-22       Impact factor: 4.507

Review 4.  Infection, inflammation, and bone regeneration: a paradoxical relationship.

Authors:  M V Thomas; D A Puleo
Journal:  J Dent Res       Date:  2011-01-19       Impact factor: 6.116

5.  Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway.

Authors:  Laura Y Lu; Florence Loi; Karthik Nathan; Tzu-Hua Lin; Jukka Pajarinen; Emmanuel Gibon; Akira Nabeshima; Luis Cordova; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Orthop Res       Date:  2017-03-13       Impact factor: 3.494

Review 6.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

7.  Dietary fat, saturated fatty acid, and monounsaturated fatty acid intakes and risk of bone fracture: a systematic review and meta-analysis of observational studies.

Authors:  H Mozaffari; K Djafarian; M D Mofrad; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

8.  Lengthening primary cilia enhances cellular mechanosensitivity.

Authors:  M Spasic; C R Jacobs
Journal:  Eur Cell Mater       Date:  2017-02-20       Impact factor: 3.942

9.  Resistance exercise and naproxen sodium: effects on a stable PGF2α metabolite and morphological adaptations of the upper body appendicular skeleton.

Authors:  Christi B Brewer; John P Bentley; Lainy B Day; Dwight E Waddell
Journal:  Inflammopharmacology       Date:  2015-08-20       Impact factor: 4.473

10.  Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading.

Authors:  Arlene J Siller-Jackson; Sirisha Burra; Sumin Gu; Xuechun Xia; Lynda F Bonewald; Eugene Sprague; Jean X Jiang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.